TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 2 | 1 | 2 | 2 | 1 | 2 | 24 | 61 | 9 | 16 |
| P | %wins | 100 | 100 | 50 | 50 | 100 | 50 | 75 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2/25/15 18:15 | 2/23/15 | ITEK | Inotek Pharmaceuticals Corp | DE | Health | Drug | Pharmaceutical Preparations | Rho Ventures IV Qp LP | NY | T | P.d | 5,749 | 6.00 | 7 | 958 | 50 | 2,871 | I | -1 | 1 | 0 | -3 | -3 | 107 | 18 | ||||||||
12/2/10 12:01 | 11/30/10 | ANAC | Anacor Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Rho Ventures IV Qp LP | NY | T | P.d | 12,000 | 5.00 | 2 | 2,400 | 75 | 5,621 | I | 0 | 3 | 2 | 6 | 50 | 15 | -1 | ||||||||
2/11/05 17:03 | 2/8/05 | TRCA | Tercica Inc | DE | Health | Drug | Pharmaceutical Preparations | Rho Ventures IV Qp LP | NY | T | P.m | 2,691 | 8.01 | 0 | 336 | 13 | 3,003 | I | |||||||||||||||
2/10/05 21:57 | 2/8/05 | TRCA | Tercica Inc | DE | Health | Drug | Pharmaceutical Preparations | Rho Ventures IV Qp LP | NY | T | P.m | 2,691 | 8.01 | 0 | 336 | 13 | 3,003 | I | |||||||||||||||
3/24/04 19:34 | 3/22/04 | TRCA | Tercica Inc | DE | Health | Drug | Pharmaceutical Preparations | Rho Ventures IV Qp LP | NY | T | P.d | 6,003 | 9.00 | 0 | 667 | 33 | 2,667 | I |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |